Please use this identifier to cite or link to this item:
Title: Rooibos, a supportive role to play during the COVID-19 pandemic?
Authors: Abdul, Naeem Sheik 
Marnewick, Jeanine L 
Keywords: Aspalathus linearis;rooibos;ACE inhibitor;cardiovascular disease;diabetes;Inflammation
Issue Date: 2021
Publisher: Elsevier
Source: Abdul, N.S. & Marnewick, J.L. 2021. Rooibos, a supportive role to play during the COVID-19 pandemic?. Journal of Functional Foods, 86: 1-12. []
Journal: Journal of Functional Foods 
Abstract: This article presents the potential health benefits of Rooibos to be considered a support during the COVID-19 pandemic. The recent pandemic of COVID-19 has led to severe morbidity and mortality. The highly infectious SARS-CoV-2 is known to prime a cytokine storm in patients and progression to acute lung injury/acute respirator distress syndrome. Based on clinical features, the pathology of acute respiratory disorder induced by SARS-CoV-2 suggests that excessive inflammation, oxidative stress, and dysregulation of the renin angiotensin system are likely contributors to the COVID-19 disease. Rooibos, a well-known herbal tea, consumed for centuries, has displayed potent anti-inflammatory, antioxidant, redox modulating, anti-diabetic, anti-cancer, cardiometabolic support and organoprotective potential. This article describes how Rooibos can potentially play a supportive role by modulating the risk of some of the comorbidities associated with COVID-19 in order to promote general health during infections.
ISSN: 1756-4646
Appears in Collections:Appsc - Journal Articles (DHET subsidised)

Files in This Item:
File Description SizeFormat 
Rooibos_supportive_role_play_during_COVID-19.pdf1.92 MBAdobe PDFView/Open
Show full item record

Google ScholarTM



Items in Digital Knowledge are protected by copyright, with all rights reserved, unless otherwise indicated.